Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uloric in Gout Patients With Moderate to Severe Renal Impairment
NCT01082640Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in gout, hyperuricemia, sponsored by Takeda. Started Apr 2010; status: completed.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT01082640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082640.